374 related articles for article (PubMed ID: 35381208)
1. "Selective" serotonin 5-HT
Casey AB; Cui M; Booth RG; Canal CE
Biochem Pharmacol; 2022 Jun; 200():115028. PubMed ID: 35381208
[TBL] [Abstract][Full Text] [Related]
2. The selective 5-HT
Jensen AA; Halberstadt AL; Märcher-Rørsted E; Odland AU; Chatha M; Speth N; Liebscher G; Hansen M; Bräuner-Osborne H; Palner M; Andreasen JT; Kristensen JL
Biochem Pharmacol; 2020 Jul; 177():113979. PubMed ID: 32298690
[TBL] [Abstract][Full Text] [Related]
3. Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes.
Borroto-Escuela DO; Romero-Fernandez W; Narvaez M; Oflijan J; Agnati LF; Fuxe K
Biochem Biophys Res Commun; 2014 Jan; 443(1):278-84. PubMed ID: 24309097
[TBL] [Abstract][Full Text] [Related]
4. Pimavanserin exhibits serotonin 5-HT
Muneta-Arrate I; Diez-Alarcia R; Horrillo I; Meana JJ
Eur Neuropsychopharmacol; 2020 Jul; 36():83-89. PubMed ID: 32517960
[TBL] [Abstract][Full Text] [Related]
5. Serotonin 5-HT
García-Bea A; Miranda-Azpiazu P; Muguruza C; Marmolejo-Martinez-Artesero S; Diez-Alarcia R; Gabilondo AM; Callado LF; Morentin B; González-Maeso J; Meana JJ
Eur Neuropsychopharmacol; 2019 Dec; 29(12):1453-1463. PubMed ID: 31734018
[TBL] [Abstract][Full Text] [Related]
6. Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors.
Vargas MV; Dunlap LE; Dong C; Carter SJ; Tombari RJ; Jami SA; Cameron LP; Patel SD; Hennessey JJ; Saeger HN; McCorvy JD; Gray JA; Tian L; Olson DE
Science; 2023 Feb; 379(6633):700-706. PubMed ID: 36795823
[TBL] [Abstract][Full Text] [Related]
7. Discovery of β-Arrestin-Biased 25CN-NBOH-Derived 5-HT
Poulie CBM; Pottie E; Simon IA; Harpsøe K; D'Andrea L; Komarov IV; Gloriam DE; Jensen AA; Stove CP; Kristensen JL
J Med Chem; 2022 Sep; 65(18):12031-12043. PubMed ID: 36099411
[TBL] [Abstract][Full Text] [Related]
8. 5-HT
Schmitz GP; Jain MK; Slocum ST; Roth BL
ACS Chem Neurosci; 2022 Aug; 13(16):2386-2398. PubMed ID: 35894503
[TBL] [Abstract][Full Text] [Related]
9. Tolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT
de la Fuente Revenga M; Jaster AM; McGinn J; Silva G; Saha S; González-Maeso J
ACS Chem Neurosci; 2022 Aug; 13(16):2436-2448. PubMed ID: 35900876
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic Activity of Substituted Tryptamines at 5-Hydroxytryptamine (5-HT)
Kozell LB; Eshleman AJ; Swanson TL; Bloom SH; Wolfrum KM; Schmachtenberg JL; Olson RJ; Janowsky A; Abbas AI
J Pharmacol Exp Ther; 2023 Apr; 385(1):62-75. PubMed ID: 36669875
[TBL] [Abstract][Full Text] [Related]
11. Hallucinogens and Serotonin 5-HT
López-Giménez JF; González-Maeso J
Curr Top Behav Neurosci; 2018; 36():45-73. PubMed ID: 28677096
[TBL] [Abstract][Full Text] [Related]
12. Serotonin 2A Receptor (5-HT
Duan W; Cao D; Wang S; Cheng J
Chem Rev; 2024 Jan; 124(1):124-163. PubMed ID: 38033123
[TBL] [Abstract][Full Text] [Related]
13. Clozapine acts as an agonist at serotonin 2A receptors to counter MK-801-induced behaviors through a βarrestin2-independent activation of Akt.
Schmid CL; Streicher JM; Meltzer HY; Bohn LM
Neuropsychopharmacology; 2014 Jul; 39(8):1902-13. PubMed ID: 24531562
[TBL] [Abstract][Full Text] [Related]
14. The role of serotonin 5-HT2A receptors in memory and cognition.
Zhang G; Stackman RW
Front Pharmacol; 2015; 6():225. PubMed ID: 26500553
[TBL] [Abstract][Full Text] [Related]
15. Behavioral arrest and a characteristic slow waveform are hallmark responses to selective 5-HT
Contreras A; Khumnark M; Hines RM; Hines DJ
Sci Rep; 2021 Jan; 11(1):1925. PubMed ID: 33479368
[TBL] [Abstract][Full Text] [Related]
16. The 5-hydroxytryptamine 2A receptor agonists DOI and 25CN-NBOH decrease marble burying and reverse 8-OH-DPAT-induced deficit in spontaneous alternation.
Odland AU; Jessen L; Kristensen JL; Fitzpatrick CM; Andreasen JT
Neuropharmacology; 2021 Feb; 183():107838. PubMed ID: 31693871
[TBL] [Abstract][Full Text] [Related]
17. In vitro assays for the functional characterization of (psychedelic) substances at the serotonin receptor 5-HT
Pottie E; Stove CP
J Neurochem; 2022 Jul; 162(1):39-59. PubMed ID: 34978711
[TBL] [Abstract][Full Text] [Related]
18. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.
Madsen MK; Fisher PM; Burmester D; Dyssegaard A; Stenbæk DS; Kristiansen S; Johansen SS; Lehel S; Linnet K; Svarer C; Erritzoe D; Ozenne B; Knudsen GM
Neuropsychopharmacology; 2019 Jun; 44(7):1328-1334. PubMed ID: 30685771
[TBL] [Abstract][Full Text] [Related]
19. Discovery and Structure-Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT
M Ro Rsted E; Jensen AA; Smits G; Frydenvang K; Kristensen JL
J Med Chem; 2024 May; 67(9):7224-7244. PubMed ID: 38648420
[TBL] [Abstract][Full Text] [Related]
20. The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug.
Jalal B
Psychopharmacology (Berl); 2018 Nov; 235(11):3083-3091. PubMed ID: 30288594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
